Other predictors of MDRTB mortality include drug resistance pattern [30], diabetes history [31], anemia, positive sputum smear, hepatitis and drug use, resistance to ofloxacin [18], HIV positive infection, and low CD4 count [29]. Here, CD4 is linked to anemia.